TransCode Therapeutics's total assets for Q4 2023 were $7.29M, a decrease of -28.72% from the previous quarter. RNAZ total liabilities were $2.71M for the fiscal quarter, a -53.24% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.